Approaches for multi-gram scale isolation of enantiomers for drug discovery

References

• Nguyen LA, He H, Chiral drugs P-HC. An overview. Int J Biomed Sci. 2006;2:85–100.
   PubMedGoogle Scholar
• Williams A. Opportunities for chiral agrochemicals. Pestic Sci. 1996;46:3–9.
   Google Scholar
• Wu Y, Miao H, Fan S. Separation of chiral pyrethroid pesticides and application in pharmacokinetics research and human exposure assessment. In: Pesticides in the modern world – effects of pesticides exposure. Baja California, Mexico InTech, ed. Margarita Stoytcheva; 2011.
   Google Scholar
• Regulation (EU) n°528/2012 concerning the making available on the market and use of biocidal products. Evaluation of active substances. Assessment Report. 2013. [cited 23 Jul 2017]. Available from: http://dissemination.echa.europa.eu/Biocides/ActiveSubstances/1409-21/1409-21_Assessment_Report.pdf
   Google Scholar
• Sekhon BS. Enantioseparation of chiral drugs – an overview. Int J PharmTech Res. 2010;2:1584–1594.
   Google Scholar
• McConathy J, Owens MJ. Stereochemistry in drug action. Prim Care Companion J Clin Psychiatry. 2003;5:70–73.
   PubMedGoogle Scholar
• Agranat I, Caner H, Caldwell J. Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov. 2002;1:753–768.
   PubMed Web of Science ®Google Scholar
• Andersoon T. Single-isomer drugs: true therapeutic advances. Clin Pharmacokinet. 2004;43:279–285.
   PubMed Web of Science ®Google Scholar
• Campo VL, Bernardes LS, Carvalho I. Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods. Curr Drug Metab. 2009;10:188–205.
   PubMed Web of Science ®Google Scholar
• Chiral technology market - global industry forecast, share, size, growth and industry analysis (2014–2020). Transparency Market Research (TMR). [cited 2 Jul 2017]. Available from: http://www.transparencymarketresearch.com/chiral-technology-market.html
   Google Scholar
• Rouf A, Taneja SC. Synthesis of single-enantiomer bioactive molecules: a brief overview. Chirality. 2014;26:63–78.
   PubMed Web of Science ®Google Scholar
• Lorenz H, Seidel-Morgenstern A. Processes to separate enantiomers. Angew Chem Int Ed Engl. 2014;53:1218–1250.
   PubMed Web of Science ®Google Scholar
• Leek H, Thunberg L, Jonson AC, et al. Klarqvist M strategy for large-scale isolation of enantiomers in drug discovery. Drug Discovery Today. 2017;22:133–139.
   PubMed Web of Science ®Google Scholar
• FDA’s policy statement for the development of new stereoisomeric drugs. Chirality. 1992;4:338–340.
   PubMed Web of Science ®Google Scholar
• Development of new stereoisomeric drugs U.S. Food and Drug Administration. 1992. [cited 7 Jul 2017]. Available from: https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm122883.htm
   Google Scholar
• Federsel HJ. Facing chirality in the 21st century: approaching the challenges in the pharmaceutical industry. Chirality. 2003;15:S128–S142.
   PubMed Web of Science ®Google Scholar
• Subramanian G. Chiral separation techniques: a practical approach. 3rd ed. Weinheim: Wiley-VCH; 2007.
   Google Scholar
• Lin GQ, You QD, Cheng JF. Overview of chirality and chiral drugs. In: Chiral drugs: chemistry and biological action. Weinheim:Wiley-VCH; 2011.
   Google Scholar
• Ali I, Suhail M, Al-Othman ZA, et al. Enantiomeric resolution of multiple chiral centres racemates by capillary electrophoresis. Biomed Chromatogr. 2016;30:683–694.
   PubMed Web of Science ®Google Scholar
• Piacentini E, Mazzei R, Giorno L. Membrane bioreactors for pharmaceutical applications: optically pure enantiomers production. Curr Pharm Des. 2017;23:250–262.
   PubMed Web of Science ®Google Scholar
• Jozwiak K. Drug stereochemistry: analytical methods and pharmacology. Boca Raton:3rd ed. CRC Press; 2012.
   Google Scholar
• Srinivas NR, Igwemezie LN. Chiral separation by high performance liquid chromatography. I. Review on indirect separation of enantiomers as diastereomeric derivatives using ultraviolet, fluorescence and electrochemical detection. Biomed Chromatogr. 1992;6:163–167.
   PubMed Web of Science ®Google Scholar
• Gaggeri R, Rossi D, Collina S, et al. Quick development of an analytical enantioselective high performance liquid chromatography separation and preparative scale-up for the flavonoid naringenin. J Chromatogr A. 2011;1218:5414–5422.
   PubMed Web of Science ®Google Scholar
• Collina S, Loddo G, Urbano M, et al. Enantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma1 ligands. Chirality. 2006;18:245–253.
   PubMed Web of Science ®Google Scholar
• Rossi D, Marra A, Rui M, et al. “Fit-for-purpose” development of analytical and (semi)preparative enantioselective high performance liquid and supercritical fluid chromatography for the access to a novel σ1 receptor agonist. J Pharm Biomed Anal. 2016;118:363–369.
   PubMed Web of Science ®Google Scholar
• Rossi D, Nasti R, Marra A, et al. Enantiomeric 4-acylamino-6-alkyloxy-2 alkylthiopyrimidines as potential A3 adenosine receptor antagonists: HPLC chiral resolution and absolute configuration assignment by a full set of chiroptical spectroscopy. Chirality. 2016;28:434–440.
   PubMed Web of Science ®Google Scholar
• Shen J, Okamoto Y. Efficient separation of enantiomers using stereoregular chiral polymers. Chem Rev. 2016;116:1094–1138.
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Ikai T. Chiral HPLC for efficient resolution of enantiomers. Chem Soc Rev. 2008;37:2593–2608.
   PubMed Web of Science ®Google Scholar
• Francotte ER. Enantioselective chromatography as a powerful alternative for the preparation of drug enantiomers. J Chromatogr A. 2001;906:379–397.
   PubMed Web of Science ®Google Scholar
• Franco P. Common screening approaches for efficient analytical method development in LC and SFC on columns packed with immobilized polysaccharide stationary phases. In Chiral separations, methods and Protocols. New York: Gerald Gübitz Martin G. Schmid (eds). 2nd ed. Humana Press; 2013.
   Google Scholar
• Francotte ER. Chromatography as a separation tool for the preparative resolution of racemic compounds. In: Chiral separations, applications and technology. Washington:American Chemical Society; 1997.
   Google Scholar
• Pirkle WH, House D, Finn J. Broad spectrum resolution of optical isomers using chiral high-performance liquid chromatographic bonded phases. J Chromatogr. 1980;192:143–158.
   Web of Science ®Google Scholar
• Davankov VA. Chiral selectors with chelating properties in liquid chromatography: fundamental reflections and selective review of recent developments. J Chromatogr. 1994;666:55–76.
   Web of Science ®Google Scholar
• Lämmerhofer M, Lindner W. Quinine and quinidine derivatives as chiral selectors I. Brush type chiral stationary phases for high-performance liquid chromatography based on cinchonan carbamates and their application as chiral anion exchangers. J Chromatogr A. 1996;741:33–48.
   Web of Science ®Google Scholar
• Ward TJ, Farris III AB. Chiral separations using the macrocyclic antibiotics: a review. J Chromatogr. 2001;906:73–89.
   PubMed Web of Science ®Google Scholar
• Haginaka J. Protein-based chiral stationary phases for high-performance liquid chromatography enantioseparations. J Chromatogr A. 2001;906(1–2):253–273.
   PubMed Web of Science ®Google Scholar
• Allenmark S, Andersson S, Möller P, et al. A new class of network-polymeric chiral stationary phases. Chirality. 1995;7:248–256.
   Web of Science ®Google Scholar
• Allenmark S, Schurig V. Chromatography on chiral stationary phases. J Mater Chem. 1997;7:1955–1963.
   Web of Science ®Google Scholar
• Miller L. Preparative enantioseparations using supercritical fluid chromatography. J Chromatogr A. 2012;1250:250–255.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee JT, Watts WL, et al. On the method development of immobilized polysaccharide chiral stationary phases in supercritical fluid chromatography using an extended range of modifiers. J Chromatogr A. 2014;1374:238–246.
   PubMed Web of Science ®Google Scholar
• Speybrouck D, Lipka E. Preparative supercritical fluid chromatography: a powerful tool for chiral separations. J Chromatogr A. 2016;1467:33–55.
   PubMed Web of Science ®Google Scholar
• Francotte E. Practical advances in SFC for the purification of pharmaceutical molecules. LCGC Europe. 2016;29:194–204.
   Web of Science ®Google Scholar
• Płotka JM, Biziuk M, Morrison C, et al. Pharmaceutical and forensic drug applications of chiral supercritical fluid chromatography. Trends Analyt Chem. 2014;56:74–89.
   Web of Science ®Google Scholar
• Welch CJ. The use of preparative chiral chromatography for accessing enantiopurity in pharmaceutical discovery and development. In Comprehensive organic synthesis. Waltham:2nd ed. Elsevier Ltd; 2014.
   Google Scholar
• Imamoglu S. Simulated moving bed chromatography (SMB) for application in bioseparation. Adv Biochem Eng Biotechnol. 2002;76:211–231.
   PubMedGoogle Scholar
• Juza M, Mazzotti M, Morbidelli M. Simulated moving-bed chromatography and its application to chirotechnology. Trends Biotechnol. 2000;18:108–118.
   PubMed Web of Science ®Google Scholar
• Rajendran A, Paredes G, Mazzotti M. Simulated moving bed chromatography for the separation of enantiomers. J Chromatogr A. 2009;1216:709–738.
   PubMed Web of Science ®Google Scholar
• Schurig V. Preparative-scale separation of enantiomers on chiral stationary phases by gas chromatography. In: Enantiomer separation: fundamentals and practical methods. Fumino Toda (ed). Springer Netherlands; 2004.
   Google Scholar
• Kinbara K. Design of resolving agents based on crystal engineering. Synlett. 2005;5:732–743.
   Web of Science ®Google Scholar
• Borghese A, Libert V, Zhang T, et al. Efficient fast screening methodology for optical resolution agents: solvent effects are used to affect the efficiency of the resolution process. Org Process Res Dev. 2004;8:532–534.
   Web of Science ®Google Scholar
• Fogassy E, Acs Maria FF. Pseudosymmetry and chiral discrimination in optical resolution via diastereoisomeric salt formation. The crystal structures of (R)- and (S)-N-methylamphetamine bitartrates (RMERTA and SMERTA). J Chem Soc Perkin Trans II. 1986;1881–1886.
   Google Scholar
• Kozma D. CRC handbook of optical resolutions via diastereomeric salt formation. Boca Raton:CRC Press; 2002.
   Google Scholar
• Guangyou Z, Yuquing L, Zhaohui W, et al. Resolution of β-aminoalcohols and 1,2-diamines using fractional crystallization of diastereomeric salts of dehydroabietic acid. Tetrahedron: Asymmetry. 2003;14:3297–3300.
   Web of Science ®Google Scholar
• Faigl F, Fogassy E, Nógrádi M, et al. Strategies in optical resolution: a practical guide. Tetrahedron: Asymmetry. 2008;19:519–536.
   Web of Science ®Google Scholar
• Kellogg RM, Kaptein B, Vries TR. Dutch resolution of racemates and the roles of solid solution formation and nucleation inhibition. Novel Optical Resolution Technologies. 2007. Kenichi Sakai, Noriaki Hirayama, Rui Tamura (eds). Springer Berlin Heidelberg.
   Google Scholar
• Vries T, Wynberg H, van Echten E, et al. The family approach to the resolution of racemates. J Angew Chem Int Ed. 1998;37:2349–2354.
   PubMed Web of Science ®Google Scholar
• Kellogg RM. Crystallization as a tool in industrial applications of asymmetric synthesis. Comprehensive Chirality 2012. Waltham: Elsevier Ltd.
   Google Scholar
• Gotrane DM, Deshmukh RD, Ranade PV, et al. A novel method for resolution of amlodipine. Org Process Res Dev. 2010;14:640–643.
   Web of Science ®Google Scholar
• Elati CR, Kolla N, Vankawala PJ, et al. Substrate modification approach to achieve efficient resolution: didesmethylcitalopram: a key intermediate for escitalopram. Org Process Res Dev. 2007;11:289–292.
   Web of Science ®Google Scholar
• Coquerel G. Preferential crystallization. In: Sakai K, Hirayama N, Tamura R, editors. Novel optical resolution technologies. Berlin, Heidelberg:Springer-Verlag; 2007. p. 1–51.
   Google Scholar
• Collet A. Separation and purification of enantiomers by crystallisation methods. Enantiomer. 1999;4:157–172.
   Google Scholar
• Jacques J, Collet A, Wilen SH. Enantiomers, racemates and resolutions. 1st ed. New York (NY): Wiley; 1991.
   Google Scholar
• Rougeot C, Hein JE. Application of continuous preferential crystallization to efficiently access enantiopure chemicals. Org Process Res Dev. 2015;19:1809−1819.
   Web of Science ®Google Scholar
• Farina V, Reeves JT, Senanayake CH, et al. Asymmetric catalysis of active pharmaceutical ingredients. Chem Rev. 2006;106:2734–2793.
   PubMed Web of Science ®Google Scholar
• Hong B-C, Raja A, Sheth VM. Asymmetric synthesis of natural products and medicinal drugs through one-pot-reaction strategies. Synthesis. 2015;47:3257–3285.
   Web of Science ®Google Scholar
• Zhan G, Du W, Chen Y-C. Switchable divergent asymmetric synthesis via organocatalysis. Chem Soc Rev. 2017;46:1675—1692.
   PubMed Web of Science ®Google Scholar
• Burke D, Henderson DJ. Chirality: a blueprint for the future. Br J Anaesth. 2002;88:563–576.
   PubMed Web of Science ®Google Scholar
• Aratikatla EK, Bhattacharya AK. Chiral pool approach for the synthesis of functionalized amino acids: synthesis of antiepileptic drug (R)-Lacosamide. Tetrahedron Lett. 2015;56:5802–5803.
   Web of Science ®Google Scholar
• Damsen H, Niggemann M. Calcium-catalyzed synthesis of 1,2-disubstituted 3-benzazepines. Eur J Org Chem. 2015;36:7880–7883.
   Web of Science ®Google Scholar
• Gnas Y, Glorius F. Chiral auxiliaries – principles and recent applications. Synthesis. 2006;12:1899–1930.
   Google Scholar
• Pignataro L, Carboni S, Civera M, et al. PhthalaPhos: chiral supramolecular ligands for enantioselective rhodium-catalyzed hydrogenation reactions. Angew Chem Int Ed. 2010;49:6633–6637.
   PubMed Web of Science ®Google Scholar
• Gajewski P, Renom-Carrasco M, Vailati Facchini S, et al. Synthesis of (R)-BINOL-derived (cyclopentadienone)iron complexes and their application in the catalytic asymmetric hydrogenation of ketones. Eur J Org Chem. 2015;2015:5526–5536.
   Web of Science ®Google Scholar
• Trost BM, Van Vranken DL. Asymmetric transition metal-catalyzed allylic alkylations. Chem Rev. 1996;96:395–422.
   PubMed Web of Science ®Google Scholar
• Di Giacomo M, Serra M, Brusasca M, et al. Stereoselective Pd-catalyzed synthesis of quaternary α-D-C-Mannosyl-(S)-amino acids. J Org Chem. 2011;76:5247–5257.
   PubMed Web of Science ®Google Scholar
• Dhar TG, Xiao HY, Xie J, et al. Identification and preclinical pharmacology of BMS-986104: a differentiated S1P1 receptor modulator in clinical trials. ACS Med Chem Lett. 2016;7:283–288.
   PubMed Web of Science ®Google Scholar
• Yang MG, Xiao Z, Murali Dhar TG, et al. Asymmetric hydroboration approach to the scalable synthesis of ((1R,3S)-1-amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2- yl)cyclopentyl)methanol (BMS-986104) as a potent S1P1 receptor modulator. J Med Chem. 2016;59:11138–11147.
   PubMed Web of Science ®Google Scholar
• Bühler S, Goettert M, Schollmeyer D, et al. Chiral sulfoxides as metabolites of 2-thioimidazole-based p38α mitogen-activated protein kinase inhibitors: enantioselective synthesis and biological evaluation. J Med Chem. 2011;54:3283–3297.
   PubMed Web of Science ®Google Scholar
• Gaich T, Mulzer J. Chiral pool synthesis: starting from terpenes. Comprehensive Chirality 2012. Waltham: Elsevier Ltd.
   Google Scholar
• Chen WW, Xu MH. Recent advances in rhodium-catalyzed asymmetric synthesis of heterocycles. Org Biomol Chem. 2017;15:1029–1050.
   PubMed Web of Science ®Google Scholar
• Anthonsen T. Reactions catalyzed by enzymes. In Applied biocatalysis. Chur:2nd ed. Taylor & Francis; 2000.
   Google Scholar
• Wells AS, Finch GL, Michels PC, et al. Use of enzymes in the manufacture of active pharmaceutical ingredients – a science and safety-based approach to ensure patient safety and drug quality. Org Process Res Dev. 2012;16:1986–1993.
   Web of Science ®Google Scholar
• Liese A, Seelbach K, Wandrey C. Industrial biotransformations. 2nd ed. Weinheim:Wiley-VCH; 2006.
   Google Scholar
• Carvalho AC, Fonseca Tde S, de Mattos MC, et al. Recent advances in lipase-mediated preparation of pharmaceuticals and their intermediates. Int J Mol Sci. 2015;16:29682–29716.
   PubMed Web of Science ®Google Scholar
• Mohamad NR, Marzuki NHC, Buang NA, et al. An overview of technologies for immobilization of enzymes and surface analysis techniques for immobilized enzymes. Biotechnol Biotechnol Equip. 2015;29:205–220.
   PubMed Web of Science ®Google Scholar
• Ismail H, Lau RM, van Rantwijk F, et al. Fully enzymatic resolution of chiral amines: acylation and deacylation in the presence of candida antarctica lipase B. Adv Synth Catal. 2008;350:1511–1516.
   Web of Science ®Google Scholar
• Blacker AJ, Stirling MJ, Page MI. Catalytic racemisation of chiral amines and application in dynamic kinetic resolution. Org Process Res Dev. 2007;11:642–648.
   Web of Science ®Google Scholar
• Hansen KB, Hsiao Y, Xu F, et al. Highly efficient asymmetric synthesis of sitagliptin. J Am Chem Soc. 2009;131:8798–8804.
   PubMed Web of Science ®Google Scholar
• Savile CK, Janey JM, Mundorff EC, et al. Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science. 2010;329:305−309.
   PubMed Web of Science ®Google Scholar
• Truppo MD, Strotman H, Hughes G. Development of an immobilized transaminase capable of operating in organic solvent. ChemCatChem. 2012;4:1071–1074.
   Web of Science ®Google Scholar
• Li H, Moncecchi J, Truppo MD. Development of an immobilized ketoreductase for enzymatic (R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethanol production. Org Process Res Dev. 2015;19:695–700.
   Web of Science ®Google Scholar
• Bryan MC, Dillon B, Hamann LG, et al. Sustainable practices in medicinal chemistry: current state and future directions. J Med Chem. 2013;56:6007–6021.
   PubMed Web of Science ®Google Scholar
• De Mas N, Natalie KJ, Quiroz F, et al. A partial classical resolution/preparative chiral supercritical fluid chromatography method for the rapid preparation of the pivotal intermediate in the synthesis of two nonsteroidal glucocorticoid receptor modulators. Org Process Res Dev. 2016;20:934–939.
   Web of Science ®Google Scholar
• Tullar BF. Optical isomers of mepivacaine and bupivacaine. J Med Chem. 1971;14:891–892.
   PubMed Web of Science ®Google Scholar
• von Langermann J, Kaspereit M, Shakeri M, et al. Design of an integrated process of chromatography, crystallization and racemization for the resolution of 2′,6′-pipecoloxylidide (PPX). Org Process Res Dev. 2012;16:343–352.
   Web of Science ®Google Scholar
• Marra A, Rossi D, Pignataro L, et al. Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist. Future Med Chem. 2016;8:287–295.
   PubMed Web of Science ®Google Scholar
• Caldwell J. Through the looking glass in chiral drug development. Mol Drug Discov. 1999;2:51–60.
   Google Scholar
• Maier NM, Franco P, Lindner W. Separation of enantiomers: needs, challenges, perspective. J Chromatogr A. 2001;906:3–33.
   PubMed Web of Science ®Google Scholar
• Shen Z, Lv C, Zeng S. Significance and challenges of stereoselectivity assessing methods in drug metabolism. J Pharmaceut Anal. 2016;6:1–10.
   PubMed Web of Science ®Google Scholar
• New drugs at FDA: CDER’s new molecular entities and new therapeutic biological products. FDA Public Health Advisory. Washington (DC): FDA/Center for Drug evaluation and Research; 2017. Available from: www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/default.htm
   Google Scholar
• Taylor LT. Supercritical fluid chromatography for the 21st century. J Supercritical Fluids. 2009;47:566–573.
   Web of Science ®Google Scholar